PubMed Health⌕ Search

Biomedical subjects

P Zickler

Publications and source records attributed to P Zickler.

13 recordsLinked to original sources

Many multipotential gene-marked progenitor or stem cell clones contribute to hematopoiesis in nonhuman primates.

Retroviral insertion site analysis was used to track the contribution of retrovirally transduced primitive progenitors to hematopoiesis after autologous transplantation in the rhesus macaque model. CD34-enriched mobilized peripheral blood cells were transduced with retroviral marking vectors containing the neo gene and were reinfused after total body irradiation. High-level gene transfer efficiency allowed insertion site analysis of individual myeloid and erythroid colony-forming units (CFU) and of highly purified B- and T-lymphoid populations in 2 animals. At multiple time points up to 1 year after transplantation, retroviral insertion sites were identified by performing inverse polymerase chain reaction and sequencing vector-containing CFU or more than 99% pure T- and B-cell populations. Forty-eight unique insertion sequences were detected in the first animal and also in the second animal, and multiple clones contributed to hematopoiesis at 2 or more time points. Multipotential clones contributing to myeloid and lymphoid lineages were identified. These results support the concept that hematopoiesis in large animals is polyclonal and that individual multipotential stem or progenitor cells can contribute to hematopoiesis for prolonged periods. Gene transfer to long-lived, multipotent clones is shown and is encouraging for human gene therapy applications.

Animals↗

Cardiac mapping.

Explore the source record for details and available documents.

Arrhythmias, Cardiac↗

Telehealth systems.

Explore the source record for details and available documents.

Biomedical Engineering↗

Cochlear implants.

Explore the source record for details and available documents.

Biomedical Engineering↗

Perspectives on dialysis therapy.

Once, patients with kidney failure faced a bleak, brief future. But now, kidney failure can successfully be treated--sometimes for decades--with dialysis. Although the technology is simple and largely painless, dialysis treatments last hours and often involve additional hours of travel to and from dialysis centers three or more days each week. This demanding schedule--combined with the life-or-death importance of treatment--involves patients and their families in a unique long-term relationship with clinicians, nurses, and technicians.

Humans↗